-
In The Wake Of Failed Merger With Aetna, Humana Regains Outperform Rating From Oppenheimer
Thursday, March 30, 2017 - 12:43pm | 458Read More...In a note released on Thursday, Oppenheimer said it is reinstating an Outperform rating on Humana Inc (NYSE: HUM), attributing the move to the termination of the company's merger with Aetna Inc (NYSE: AET). The firm has a 12–18-month price target of $236 for the company. The firm presented...
-
Oppenheimer Reiterates Air Methods (AIRM) Outperform Rating
Friday, March 12, 2010 - 9:31am | 104Read More...Oppenheimer analysts Michael Wiederhorn, Matt Nirenberg and Jeffrey Fedder reiterated their Outperform rating for shares of Air Methods Corporation (Nasdaq: AIRM), with a price target of $38. The analysts believe that Air Methods Corporation's disappointing results were due to poor weather...
